Arteris Inc

For the period ended Dec 31, 2023. Filed Feb 20, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 20, 2024

AIP$19.20+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands, except share and per share data)

	As of December 31,
	2023	2022
ASSETS
Current assets:
Cash and cash equivalents	$13,696	$37,423
Short-term investments (Note 5)	27,477	30,728
Accounts receivable, net of allowance of $93 and $250 as of December 31, 2023 and 2022, respectively	12,003	7,143
Prepaid expenses and other current assets	5,254	5,818
Total current assets	58,430	81,112
Property and equipment, net	5,745	3,617
Long-term investments (Note 5)	11,802	4,427
Equity method investment	8,500	11,897
Operating lease right-of-use assets	4,289	1,883
Intangibles, net	3,858	4,575
Goodwill	4,178	4,218
Other assets	5,999	3,787
TOTAL ASSETS	$102,801	$115,516
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$183	$572
Accrued expenses and other current liabilities	11,831	12,095
Operating lease liabilities, current	781	899
Deferred revenue, current	31,537	28,839
Vendor financing arrangements, current	2,070	1,264
Total current liabilities	46,402	43,669
Deferred revenue, noncurrent	25,172	21,840
Operating lease liabilities, noncurrent	3,610	1,009
Vendor financing arrangements, noncurrent	1,292	448
Deferred income, noncurrent	8,810	9,993
Other liabilities	2,412	1,022
Total liabilities	87,698	77,981
Commitments and contingencies (Note 12)
Stockholders’ equity:
Preferred stock, par value of $0.001—10,000,000 shares authorized and no shares issued and outstanding as of both December 31, 2023 and 2022	—	—
Common stock, par value of $0.001—300,000,000 shares authorized at December 31, 2023 and 2022; 37,518,583 and 34,625,875 shares issued and outstanding at December 31, 2023 and 2022, respectively	37	34
Additional paid-in capital	118,193	103,778
Accumulated other comprehensive income	120	101
Accumulated deficit	(103,247)	(66,378)
Total stockholders’ equity	15,103	37,535
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$102,801	$115,516

See notes to consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.